Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| LPCN | 8-K | neutral | 2/10 | Lipocine Inc. filed an 8-K announcing management will present and meet with investors at the H.C. Wainwright 28th Annual | Sep 10, 2026 |
| CPS | 8-K | bullish | 6/10 | Cooper-Standard Holdings (CPS) entered into Amendment No. 6 to its ABL credit facility, increasing total commitments by | Sep 10, 2026 |
| SEDG | 8-K | neutral | 2/10 | SolarEdge filed an 8-K announcing its 2026 Investor Day webcast on September 10, 2026. Management will discuss strategy, | Sep 10, 2026 |
| FLWS | 8-K | bearish | 7/10 | 1-800-FLOWERS.COM reported fiscal Q4 2026 revenue of $293.1M (-12.9% YoY) and an adjusted net loss of $-0.80/share, miss | Sep 10, 2026 |
| TRMK | 8-K | neutral | 5/10 | Trustmark Bank completed a $91.7 million sale-leaseback of 34 branch properties to Blue Owl Real Estate Capital, generat | Sep 10, 2026 |
| MCFT | 8-K | mixed | 6/10 | MasterCraft Boat Holdings reported fiscal Q4 2026 GAAP loss from continuing ops of $(0.35)/share vs consensus $0.60, a 1 | Sep 10, 2026 |
| VNCE | 8-K | bullish | 6/10 | Vince Holding Corp. reported Q2 2026 net sales of $81.8M, up 11.7% YoY, and adjusted EPS of $1.02, well above the $0.27 | Sep 10, 2026 |
| LOVE | 8-K | neutral | 5/10 | Lovesac reported Q2 FY2027 net sales of $161.2M, essentially flat YoY (+0.4%), and GAAP EPS of $0.51, a significant swin | Sep 10, 2026 |
| CC | 8-K | bullish | 7/10 | Chemours, along with DuPont and Corteva, entered into a $455 million settlement agreement with the State of North Caroli | Sep 10, 2026 |
| SHOE | 8-K | bearish | 7/10 | Shoe Station Group (SHOE) reported Q2 2026 GAAP EPS of $0.23, a 67% decline from $0.70 in Q2 2025 and a 32% miss vs the | Sep 10, 2026 |
| SWMR | 8-K | bullish | 7/10 | Swarmer (SWMR) entered into a definitive agreement to acquire Ratel Robotics, a Ukrainian UGV manufacturer, for up to $2 | Sep 10, 2026 |
| M | 8-K | bullish | 7/10 | Macy's Q2 2026 results beat expectations with GAAP EPS of $0.62 (up 100% YoY) and adjusted EPS of $0.63, driven by 2.7% | Sep 10, 2026 |
| DBI | 8-K | bullish | 7/10 | Designer Brands reported Q2 2026 adjusted diluted EPS of $0.34, significantly exceeding the $0.26 consensus estimate, an | Sep 10, 2026 |
| ELV | 8-K | neutral | 3/10 | Elevance Health filed an 8-K to reaffirm its full-year 2026 guidance during upcoming investor meetings. The company expe | Sep 10, 2026 |
| AITX | 8-K | neutral | 2/10 | AITX announced the commercial availability of SARA Assess, a new software integration with Circadian Risk that extends i | Sep 10, 2026 |
| BRO | 8-K | neutral | 2/10 | Brown & Brown filed an 8-K furnishing a 2026 company overview investor presentation under Item 7.01 Regulation FD. The p | Sep 10, 2026 |
| BHVN | 8-K | bearish | 7/10 | Biohaven disclosed that the FDA issued a partial clinical hold letter on September 4, 2026, pausing new patient enrollme | Sep 10, 2026 |
| AXGN | 8-K | bullish | 7/10 | Axogen announced a $200M cash acquisition of BioCircuit Technologies (NerveTape sutureless nerve repair device) and simu | Sep 10, 2026 |
| GPI | 8-K | mixed | 6/10 | Group 1 Automotive priced a $1.25B private placement of senior notes (6.250% due 2032 and 6.625% due 2035) to fund its p | Sep 10, 2026 |
| NWSA | 8-K | neutral | 3/10 | News Corp filed an 8-K to disclose its daily buy-back notification to the Australian Securities Exchange (ASX) under its | Sep 10, 2026 |
| INDP | 8-K | bearish | 7/10 | Indaptus Therapeutics entered into a stock purchase agreement for a $24M private placement of 20,338,974 shares, priced | Sep 10, 2026 |
| AMZN | 8-K, 3 | neutral | 2/10 | Amazon elected Kevin R. Mandia as a new director on September 8, 2026, appointing him to the Audit and Security Committe | Sep 9, 2026 |
| CADL | 8-K | neutral | 4/10 | Candel Therapeutics filed an 8-K furnishing a September 2026 corporate investor presentation. The presentation highlight | Sep 9, 2026 |
| CTBI | 8-K | neutral | 3/10 | Community Trust Bancorp (CTBI) filed an 8-K to furnish an investor presentation for the Raymond James U.S. Bank and Bank | Sep 9, 2026 |
| POLE | 8-K | neutral | 4/10 | Andretti Acquisition Corp. II entered into additional non-redemption agreements with new investors ahead of its Septembe | Sep 9, 2026 |
| GCTK | 8-K | bearish | 7/10 | Glucotrack entered a Settlement and Release Agreement with Alto Opportunity Master Fund to resolve a dispute over approx | Sep 9, 2026 |
| EDUC | 8-K | neutral | 2/10 | Educational Development Corp filed an 8-K announcing the date of its fiscal year 2027 second quarter earnings call, sche | Sep 9, 2026 |
| FMBM | 8-K | neutral | 2/10 | F&M Bank Corp. filed an 8-K to announce that management will present at the Raymond James U.S. Bank Conference on Septem | Sep 9, 2026 |
| UNFI | 8-K | bullish | 6/10 | UNFI reported Q4 fiscal 2026 results with net sales of $7.64B (down 0.7% YoY) and GAAP EPS of $0.57, while Adjusted EPS | Sep 9, 2026 |
| ABM | 8-K | mixed | 6/10 | ABM reported fiscal Q3 2026 results with revenue of $2.317B (+4.2% YoY) and adjusted EPS of $1.04, which missed the cons | Sep 9, 2026 |